Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
PEAR1 Biologics Sequence Review Report 2026: Platelet endothelial aggregation receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PEAR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PDCD1LG2 Biologics Sequence Review Report 2026: Programmed cell death 1 ligand 2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PDCD1LG2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
PAGE4 Biologics Sequence Review Report 2026: P antigen family member 4 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of PAGE4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OXGR1 Biologics Sequence Review Report 2026: 2-oxoglutarate receptor 1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OXGR1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OSMR Biologics Sequence Review Report 2026: Oncostatin-M-specific receptor subunit beta Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OSMR sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR8G1 Biologics Sequence Review Report 2026: Olfactory receptor 8G1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR8G1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR7D4 Biologics Sequence Review Report 2026: Olfactory receptor 7D4 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR7D4 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR6A2 Biologics Sequence Review Report 2026: Olfactory receptor 6A2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR6A2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR5AN1 Biologics Sequence Review Report 2026: Olfactory receptor 5AN1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR5AN1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR51E2 Biologics Sequence Review Report 2026: Olfactory receptor 51E2 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR51E2 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR1A1 Biologics Sequence Review Report 2026: Olfactory receptor 1A1 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR1A1 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
OR10J5 Biologics Sequence Review Report 2026: Olfactory receptor 10J5 Similarity and Patent-Risk Signals
17 September 2026
A Biology Modality MCP review of OR10J5 sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
875
876
877
878
879
>>
2926
>